My best collaborators are women, says Gagandeep Kang, the first Indian woman Fellow of the Royal Society
Kang is acclaimed for her key role in the development of Rotavac, India’s first indigenously developed vaccine for rotavirus infections Gagandeep Kang, 56, is Director of the Translational Health Science and Technology Institute (THSTI) in Faridabad. Acclaimed for her key role in the development of Rotavac, India’s first indigenously developed vaccine for rotavirus infections, Kang was recently awarded Fellowship of the Royal Society (FRS), United Kingdom — the first Indian woman scientist to be thus feted. In an interview, she spoke about the challenges of being a woman scientist in India and why the country would do well with a 40% job reservation for women. Excerpts: Do you think the ‘woman scientist tag’ occludes your achievements as a scientist? I was once awarded a ‘Woman Bioscientist of the Year’ prize. The first time I got it, I thought, ‘That’s nice,’ but I’d rather be competing on a stage where gender doesn’t matter. The nice thing about the FRS is that th...